MedCity News August 19, 2024
Sandra Clarke

We can’t wait for others to find a solution to high drug prices. It’s clear what should happen in a functioning drug pricing market federally and in California, but it is not happening today.

The healthcare industry is hungry for innovation, and a properly functioning market should make that innovation possible. So why do we continue to see an unsustainable rise in drug costs? Why is medication affordability and accessibility still lagging so far behind? While there is no consensus on how to fix the broken drug pricing and rebate system, California has more opportunities than ever before to address prescription drug affordability by focusing on the pharmaceutical benefit manager (PBM) middlemen that can drive up costs.

We can’t...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Axolotl Biosciences Brings Biotech to the Forefront at Formnext 2024
Innovative approach maps gene activity in the living human brain
Trump tariffs could drive up generic drug costs: 5 takeaways
Bridging the Gap: Pharmacists' Role in Advancing Pharmacogenomic Testing Standards

Share This Article